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Objectives: The French “liste-en-sus” was implemented to support an equal access 
to innovative and higly-priced medicines. The methodology to define the scope of 
this list has been updated recently. Listing or delisting is now decided per therapeu-
tic indication and no longer by product. Our aim is to assess the relevance of listed 
therapeutic indications in accordance with the updated methodology. MethOds: 
Using the health technology assessment published by the Transparency Committee, 
we gathered for each medicine included on the liste-en-sus (excluding blood-
derived products) until march 1st, 2015 : assessment date, marketing authorization 
date, medical benefit and improvement in medical benefit (IMB) scores and medi-
cine comparator. We selected therapeutic indications wich fulfilled both criteria : 
no IMB and the comparator is financed by diagnosis-related groups (DRGs). Using 
the French medicalized information system program, we identified International 
classification of diseases (ICD-10) codings groups and we collected expenditures 
corresponding to these indications in France in 2013. Results: The liste-en-sus 
includes 214 indications. IMB is available in 87% of cases. 6% of indications have 
been evaluated before 2005. Another 7% are extensions of indication and they have 
not been assessed yet as marketing authorization has been granted recently. Among 
the 32% of indications showing no IMB, the comparator is financed by DRGs in 7% 
of cases (16 indications or 11 medicines). The 12 ICD-10 codings groups correspond-
ing to these 16 indications show an expenditure of EUR 450.5 million. This amount 
represents 16% of the total expenditures (EUR 2.8 billion) for all medicines included 
on the liste-en-sus in 2013. cOnclusiOns: From now on, all indications including 
extensions of indication have to be evaluated before being registered on the liste-
en-sus by analyzing the health technology assessment published. 16 therapeutic 
indications are not matching the criteria defined in the new methodology.
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Objectives: With the accelerated aging trend of the population and transforma-
tion of lifestyle, fundamental changes have taken place in disease spectrum of our 
human beings, anda major threat to human health has been gradually shifting 
from infectious diseases to chronic non-communicable diseases. Basing on above, 
an ecological model that derived from Bronfenbrenner’s ecology of human develop-
ment theory was proposed as a theory-based framework to analysis the risk factors 
of chronic diseases. Combined with the characteristics of chronic diseases, as well 
as sociology, policy science and related theory, the ecological model was elaborated 
to personal traits, behavior characteristics, family microsystem, work microsystem 
and the policy environment variables. MethOds: Cross-section data of CHARLS 
(China Health and Retirement Longitudinal Study) 2013 which includes about 10,000 
households and 17,500 individuals in 150 counties/districts and 450 villages/resident 
committees was adopted to conduct the empirical study. Two Methods of regression 
analysis evolved from two-part models and descriptive statistically analysis were 
combined to analysis the effects of different influence factors on the prevalence and 
sicken age. Results: Firstly, personal traits and behavioral characteristics are the 
primary factors which influence the prevalence of chronic diseases; Secondly, family 
microsystem, work microsystem can also have important effects on chronic disease 
prevalence and sicken age; thirdly, financial situation have non-continuous influ-
ence on chronic disease prevalence, which means only low standard of living will 
affect the incidence of chronic diseases. cOnclusiOns: Some effective measures 
should be put forward to improve the chronic disease prevention and control work. 
Firstly, relevant departments should be undertaken by changing health development 
mode and carrying out prevention policy; Secondly, comprehensive intervention 
should be carried out in the community; Thirdly, basic medical insurances for low-
income people to affordable health services should be guaranteed.
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Objectives: To investigate the trends in antibiotic resistance and antibiotic prescrip-
tion between 2007 and 2014 in the St. Petersburg State Medical University. MethOds: 
Data on patient demographics, length of stay in hospital, clinical outcomes, antibiotic 
usage and antibiotic susceptibility were retrospectively gathered for 3000 patients 
across 7 hospital wards between the years 2008 and 2014. Patients were eligible if 
they presented with or had any bacterial infection in hospital and had a microbio-
logical sample taken whilst in hospital. Across the same period, inpatient antibiotic 
prescriptions in the hospital pharmacy were gathered on a monthly basis and con-
verted into their defined daily dose (DDD) per 100 bed-days. Results: The most 
common infections were intra-abdominal (43%) and urinary tract (42%). Just over 
3,800 microbiological samples were collected over the study period for culture and 
susceptibility. Fourteen percent of these showed the isolated microorganism being 
resistant to the antibiotic it was tested against. This was highest in 2014 where the 
level of overall resistance reached 17%. The prevalence of extended spectrum beta-
lactamases (ESBLs) increased from 3% in 2008 to 11% in 2014. The data show that levels 
of Escherichia coli bacterial resistance doubled over the 7-year period from 11% to 22% 
with its resistance to ceftriaxone increasing from 2% in 2008 to 22% in 2014. Across 
the same time period the prescription of antibiotics, as measured by DDD, increased 
by 9.8%, with prescriptions of carbapenems increasing by 64%. cOnclusiOns: 
ers and specialists, hospital admissions within the last 12 months, and number of 
medications taken at least once a week. The results were presented according to 
age (in 5-year intervals), gender, education and subjective perception of income. 
Analyses of bivariate relationship dependency were performed by Pearson’s 
chi-square test and Cramer’s contingency coefficient, wherein the value of p < 
0.05 marked the significance level. Results: The analysis showed as intuitively 
expected that older individuals in Slovenia more often seek ambulatory medical 
care, take multiple medications and are hospitalized at a higher rate. The only 
exception was the oldest seniors (85+) group, in which we observed that the uti-
lization of health services was lower than in the age group from 70 to 79 years. 
Besides age, education was an important factor that influenced the use of health 
care services, while income significantly affected only the number of contacts with 
general practitioners. cOnclusiOns: Our findings are important as the basis for 
the planning and implementation of health care system in Slovenia, particularly 
in the current conditions of austerity measures, changing demographic structure 
and rapid technological progress of medicine.
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Objectives: To establish reliability and validity of a Value Added Services 
Questionnaire (VASQ) using themes generated from interviews based on Theory 
of Planned Behaviour. MethOds: Using an extended Theory of Planned Behavior 
(TPB) as the theoretical model, face-to-face interviews generated salient beliefs 
of VAS. The VASQ questionnaire was constructed initially in English incorporat-
ing important themes and later translated into the Malay language with forward 
and backward translation. Intention (INT) to adopt VAS is predicted by Attitudes 
(ATT), Subjective Norms (SN), Perceived Behavioral Control (PBC), Knowledge and 
Expectations. Using a 7-point Likert-type scale and a dichotomous scale, test-
retest reliability (N = 25) was assessed by administrating the questionnaire instru-
ment twice at an interval of one week apart. Internal consistency was measured 
by Cronbach’s alpha and construct stability between two administrations was 
assessed using the kappa statistic and the Intraclass correlation coefficient (ICC). 
Confirmatory factor analysis (N = 410) was conducted to assess construct validity of 
the VASQ. Results: The kappa coefficients indicate a moderate to almost perfect 
strength of agreement between test and retest. The ICC for all scales tested for intra-
rater (test-retest) reliability was good . The overall Cronbach’ s alpha (N = 25) is 0.912 
and 0.908 for the two time points. The result of factor analysis (N = 410) showed 
most items loaded strongly and correctly into corresponding factors. Only one item 
is suggested to be eliminated. cOnclusiOns: This study is the first to develop 
and establish the reliability and validity of the Value Added Services Questionnaire 
instrument using the Theory of Planned Behaviour as the theoretical model. The 
translated Malay language version of VASQ is reliable and valid to predict Malaysian 
patients’ intention to adopt VAS to collect partial medicine supply.
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Objectives: To evaluate whether consumer-directed health plans (CDHPs) lead 
patients to shop for lower-cost office visits. MethOds: We started by comparing 
the prices paid by patients in CDHPs versus traditional plans. However, this simple 
approach had two potential bias sources: 1) differences in negotiated prices between 
CDHPs and traditional plans and 2) difference in patients’ preferences for price shop-
ping. Therefore, we first examined the negotiated price difference within the same 
provider and then investigated the Pre- (and post-) CDHP enrollment patients’ price 
shopping behavior within the same plan and hospital referral region (Plan-HRR). 
Finally, we estimated the effect of CDHP enrollment under difference-in-difference 
(DID) frameworks. We used longitudinal claims data comparing patients switch-
ing from traditional plans in pre year to CDHPs in post year (treatment group) with 
patients remaining in traditional plans (control group). The outcomes were the total 
price on the patient level and the percentile of the price within a Plan-HRR. Results: 
CDHP patients paid higher price than controls, but even the same provider charged 
significantly higher price from CDHP patients (β = 1.959±0.112, P< 0.01). Prior to CDHP 
enrollment, patients in the treatment group paid slightly lower than the controls 
but not statistically significant (β = -0.528±0.328, P= 0.108). Post-enrollment adjusted 
price was significantly lower in the treatment group (β = -2.224±0.392, P< 0.01), which 
resulted in a slight but significant reduction in price paid by patients switching to 
CDHPs (price DID estimate: -1.697±0.504, P= 0.001; percentile of price DID estimate: 
-0.900±0.480, P= 0.061). Moreover, switching to CDHPs and simultaneously switching 
providers are associated with larger effects in price shopping relative to CDHP patients 
not switching providers, but the magnitude of the difference was small (price DID 
estimate: -2.188±0.605 vs. -0.491±0.462, P= 0.0045; percentile of price DID estimate: 
-1.631±0.592 vs. -0.130±0.452, P= 0.0151). cOnclusiOns: Switching to CDHPs does 
lead patients shop for lower-cost office visits but the savings are modest.
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